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Abstract
Background: Molecular epidemiological studies of HIV-1 in South America have revealed the occurrence of
subtypes B, F1 and BF1 recombinants. Even so, little information concerning the HIV-1 molecular epidemiology in
Bolivia is available. In this study we performed phylogenetic analyses from samples collected in Bolivia at two
different points in time over a 10 year span. We analyzed these samples to estimate the trends in the HIV subtype
and recombinant forms over time.
Materials and methods: Fifty one HIV-1 positive samples were collected in Bolivia over two distinct periods (1996
and 2005). These samples were genetically characterized based on partial pol protease/reverse transcriptase (pr/rt)
and env regions. Alignment and neighbor-joining (NJ) phylogenetic analyses were established from partial env (n =
37) and all pol sequences using Mega 4. The remaining 14 env sequences from 1996 were previously characterized
based on HMA-env (Heteroduplex mobility assay). The Simplot v.3.5.1 program was used to verify intragenic
recombination, and SplitsTree 4.0 was employed to confirm the phylogenetic relationship of the BF1 recombinant
samples.
Results: Phylogenetic analysis of both env and pol regions confirmed the predominance of “pure” subtype B
(72.5%) samples circulating in Bolivia and revealed a high prevalence of BF1 genotypes (27.5%). Eleven out of 14
BF1 recombinants displayed a mosaic structure identical or similar to that described for the CRF12_BF variant, one
sample was classified as CRF17_BF, and two others were F1pol/Benv. No “pure” HIV-1 subtype F1 or B” variant of
subtype B was detected in the present study. Of note, samples characterized as CRF12_BF-related were depicted
only in 2005.
Conclusion: HIV-1 genetic diversity in Bolivia is mostly driven by subtype B followed by BF1 recombinant strains
from the CRF12_BF “family”. No significant temporal changes were detected between the mid-1990s and the mid-
2000s for subtype B (76.2% vs 70.0%) or BF1 recombinant (23.8% vs 30.0%) samples from Bolivia.
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Background
Latin America contains the third highest estimated
number of people living with HIV in the world [1]. The
HIV epidemic in countries from the Southern Cone is
characterized by the co-circulation of HIV-1 subtypes B,
F1, and BF1 recombinant forms [2-4]. Despite such
overall similarity, the mosaic patterns of the HIV-1 BF1
Circulanting Recombinant Forms (CRFs_BF) and
Unique Recombinant Forms (URFs_BF) display some
important differences among countries.
The HIV-1 BF1 epidemics in Argentina [5-9], Chile
[10], Paraguay [11] and Uruguay [12] are dominated by
the CRF12_BF and URFs_BF sharing CRF12-related
structures, in other words sharing some of CRF12_BF
breakpoints. In addition, new local CRFs_BF with a
CRF12-related structure have been identified within
each country, including CRF17_BF in Argentina and
Paraguay [9,11], CRF38_BF in Uruguay [12], and
CRF44_BF in Chile [13]. By contrast, the HIV-1 BF1
Brazilian epidemic is driven mainly by a myriad of dif-
ferent URFs_BF and at least five distinct CRFs_BF
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[14-19], unrelated to CRF12_BF, which usually show no
common mosaic recombinant profile among one
another. Another important difference is that some
“pure” full-length subtype F1 genomes have been
described in Brazil [20], while the frequency of such
full-length subtype F1 viruses or even non-recombinant
subtype F1 pol sequences is almost absent in other
South American countries [8,12,21,22].
Bolivia is a landlocked country in central South Amer-
ica, bordered by Brazil to the north and east, Paraguay
and Argentina to the south, and Chile and Peru to the
west. The total number of HIV/AIDS cases reported in
Bolivia was 5,184 from 1984 through March 2010 [23],
with an estimated country-wide underreporting rate of
over 70% [24]. UNAIDS estimates that approximately
12,000 people in Bolivia were living with HIV in 2009,
and of those cases, 500 to 1500 were new infections [1].
These estimates demonstrate that the Bolivian epidemic
is still potentially growing. Very scarce data on HIV epi-
demiology in Bolivia are available, with only two major
previous studies conducted in the 1990s, which revealed
the occurrence of subtypes B, F1 and BF1 recombinant
forms [22,25], similar to what has been described for
other countries from the Southern Cone [2-13]. In these
previous studies, however, most samples were geneti-
cally characterized on the basis of HMA env analysis,
and very few (n = 14) HIV-1 nucleotide sequences from
Bolivian seropositive patients are available at the Los
Alamos HIV database, from those only three were full
length genomes that reveal the circulation of CRF12_BF
[5] and CRF17_BF.
The objective of the present study was to assess the
trends in the HIV molecular epidemiology in Bolivia
based on the phylogenetic analysis of HIV-1 pol and env
sequences at two different time points (1996 and 2005).
Results
In order to assess the trends of the HIV-1 molecular
epidemiology in Bolivia, 62 samples were collected at
two points in time, 1996 (30 samples) and 2005 (32
samples), and submitted to amplification and sequencing
of both the pol (pr/rt) and env genomic regions. Eleven
samples (nine from 1996 and two from 2005) failed to
be amplified or sequenced from the proviral DNA in
one or both genomic regions and were excluded from
the study. The remaining 51 samples showed a predomi-
nance of the B subtype (72.5%) and BF1 recombinants
(27.5%) (Figure 1). Of note, no pure subtype F1 genomes
(F1pol/F1env) were detected. Fourteen highly supported
(> 95%) monophyletic clusters of at least two sequences
could be detected in the pol (Figure 1a) and 11 in env
region (Figure 2b). Some clusters were composed of
sequences retrieved from individuals with a known
direct epidemiological link, such as sexual partners
(clusters 2a, 5 and 6a), and a mother/child pair (cluster
7). No apparent direct epidemiological relationships
were detected for the remaining 10 clusters (1, 2, 3, 4, 6,
8, 9, 10, 11, 12). Among the 12 monophyletic clusters,
nine displayed a Bpol/Benv profile (1-9), two were
BF1pol/F1env (10, 11), and one was F1pol/Benv (12)
(Figure 1).
The 14 BF1 recombinant samples identified in this
study displayed the following recombination profiles:
BF1pol/F1env (n = 11), BF1pol/Benv (n = 1) and F1pol/
Benv (n = 2) (Figure 1). A more detailed evaluation of
the 12 BF1 pol recombinant samples was performed
using bootscan and SplitsTree analyses. From these, five
samples displayed a recombination profile in pr/rt iden-
tical to the CRF12_BF, being classified as CRF12_BF-like
(96BOLP29, 96BOSC14, 05BO06, 05BO15, 05BO18),
and one sample exhibited a CRF17_BF-like mosaic pat-
tern (96BOLP23) (Figure 2).
No epidemiological data were available to confirm the
proposed close genetic relationship between the
CRF17_BF (BO02.BO119) strain available in the Los
Alamos Sequence Database and the BF recombinant
genome described in the present study. The remaining
six BF1 pol samples segregate in two highly supported
monophyletic clusters and exhibited two different
CRF12_BF-related (F1/B/F1/B) mosaic profiles (Figure
2). In the first cluster (cluster 10), which is composed of
samples 05BO09 and 05BO20, the first (F1/B) and sec-
ond (B/F1) recombination breakpoints at pol coincide
with those observed in the CRF12_BF, while the third
one (F1/B) is displaced downstream. In the second clus-
ter (cluster 11), which is composed of samples 05BO03,
05BO16, 05BO22 and 05BO24, only the third (F1/B)
recombination breakpoint at pol coincides with those
observed in the CRF12_BF, while the first (F1/B) and
the second (B/F1) recombination breakpoints at pol
were displaced upstream in comparison to those
detected in CRF12_BF (Figure 3). None of the CRFs_BF
pol mosaic patterns described in Brazil (CRF28, CRF29,
CRF39, and CRF40), Uruguay (CRF38), or Chile
(CRF44) was observed for the HIV-1 samples obtained
from Bolivia.
Table 1 summarizes the subtype distribution and
recombination profiles of the 51 HIV-1 samples from
Bolivia according to the time period. No significant tem-
poral change in the HIV-1 subtype distribution was
observed in Bolivia between 1996 and 2005. During this
period the prevalence of subtype B decreased from
76.2% to 70%, while the prevalence of BF1 recombinants
increased from 23.8% to 30%.
Discussion
The present study represents the most comprehensive
analysis of the HIV-1 molecular diversity in Bolivia
Guimarães et al. Virology Journal 2012, 9:19
http://www.virologyj.com/content/9/1/19
Page 2 of 7
performed to date. From a total of 51 samples investi-
gated in both pol (pr/rt) and env (C2-V3) regions, 72.5%
of cases were classified as “pure” subtype B, and 27.5%
were classified as BF1 recombinants. Eleven out of 14
BF1 recombinants displayed a mosaic structure identical
or similar to that described for the CRF12_BF strain,
and the remaining two BF1 recombinants displayed a F1
(pol)/B(env) mosaic structure. Subtype F1 (pol)/F1 (env)
strains were not detected in the present study.
The high frequency of BF1 recombinants with
CRF12_BF-like or CRF12_BF-related structures and the
absence of non-recombinant subtype F1 strains found in
Bolivia reveal a scenario closely related to that found in
Argentina, Chile, Paraguay and Uruguay [6-12], and dif-
ferent from that found in other neighboring countries,
such as Brazil and Peru [17-19,22]. This pattern suggests
a more intense HIV-1 influx into Bolivia from the
southern border (Argentina and/or Paraguay) than from
the eastern (Peru) or western/northern (Brazil) frontiers.
It is interesting to note that none of the subtype B sam-
ples studied presented the typical Brazilian motif
GWGR in the top of the v3 loop (B” variant of subtype
B), which is highly (40%) represented in Brazil [26]. The
reason for such potential unequal viral genetic influxes
into Bolivia from neighboring countries remains
unknown and deserves further investigation.
In addition to the widely disseminated CRF12_BF var-
iant, other CRFs_BF variants with a CRF12_BF-related
structure were also described as circulating in Argentina
and Paraguay (CRF17_BF), Uruguay (CRF38_BF) and
Chile (CRF44_BF) [9-13]. One sequence with a
CRF17_BF-like recombinant structure was also detected
in our study, confirming the circulation of this CRF in
Bolivia since 1996. Of note, we also detected one highly
supported cluster (cluster 11) of four BF1 sequences dis-



































































































































































































































Figure 1 Phylogenetic analysis of 51 HIV-1 pol (a) and 37 env (b) samples from Bolivia. Bootstrap values ≥70% supporting nodes are
shown on the left of each node and were estimated using the neighbor-joining with Tamura-Nei substitution model. The scale bar indicates
10% nucleotide sequence divergence. HIV-1 samples analyzed in the present study were in bold format. Arrows indicate those samples with
intergenic recombination. Highly supported (> 95%) monophyletic clusters are highlighted and numbered.
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mosaic profile, obtained from epidemiologically unlinked
HIV-1 seropositive patients from Bolivia. Such a result
may represent a new local Bolivian CRF_BF variant.
Full-length genome analysis of these four BF1 sequences
will be necessary to confirm this hypothesis.
It is interesting to note that all BF1 recombinants with
a CRF12_BF-related structure detected in Bolivia dis-
played larger subtype B segments at pol than CRF12_BF.
A similar finding was also observed in Argentina [5-9]
and Chile [10]. The generation of CRF12_BF-related
recombinants with larger subtype F1 fragments in those
countries is unexpected because of the scarcity (or com-
plete absence) of pure subtype F1 variants outside of
Brazil. It has been proposed that the CRF12_BF strain
and other CRFs_BF and URFs_BF variants with related
structures circulating in South America, as well as other
groups of related recombinants should be considered
components of the same “family” of recombinants [3,27].
Since its emergence around the early 1980s, the
CRF12_BF variant has displayed an initial exponential
expansion in Argentina and Uruguay [28]. Such a fast
rate of spread and the high prevalence (> 50%) of
CRF12_BF and CRF12_BF-related mosaic forms in those
countries could be interpreted as evidence of the high
viral fitness and/or transmissibility of the CRF12
“family” of recombinants. However, much lower preva-
lence (< 25%) of CRF12_BF-like and CRF12_BF-related
variants has been found in Bolivia [this study], Chile
[10] and Paraguay [11]. Our results did not depict a sig-
nificant increase in the proportion of those mosaic HIV-
1 forms in Bolivia between 1996 and 2005, nevertheless
all samples from 2005 were collected in only one city:
La Paz. This finding suggests that the rate of expansion
and the resulting prevalence of CRF12_BF “family” var-
iants in South America are country-specific and might













Figure 2 SplitsTree analysis of the HIV-1 Bolivian BF1 pol regions. The splits graph was constructed using NeighborNet methodology with
pairwise distance input, which was estimated by F84 distance. The scale bar indicates 10% nucleotide sequence divergence. Reference
sequences were indicated by subtype letter or CRF number. The alignment was prepared with HIV-1 group M subtypes B and F1 and CRF_BFs
from South America. Four clusters containing studied samples were detected and are indicated with a circle. Representative bootscanning plots
were generated for each cluster. Bootscan analysis was performed on a sliding window of 200 nt of the query sequences moving along an
alignment of reference sequences by increments of 20 nt. Reference samples used for these analyses are discriminated in the figure legend.
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also proposed that the prevalence of CRF12_BF and
related BF1 strains is higher in countries with more
extensive intravenous drug epidemics, possibly due to a
founder effect and the rapid spread of HIV in these
groups [22].
Conclusion
In summary, our results demonstrate that HIV-1 genetic
diversity in Bolivia is mostly driven by subtype B
followed by BF1 recombinant strains from the
CRF12_BF “family” and no significant temporal changes
in the subtype distributions were detected between the
mid-1990s and the mid-2000s.
Materials and methods
Study population
A set of 62 samples were collected in Bolivia in 1996 (30
samples) and 2005 (32 samples). Demographic, labora-
tory and clinical data of Bolivian subjects collected in
1996 were previously described [24]. Samples from 1996
were collected in three distinct Bolivia cities [La Paz (n
= 9), Cochabamba (n = 5) and Santa Cruz (n = 16)].
The second cohort was composed exclusively of patients
living in La Paz, and most of them were under antiretro-
viral therapy. All participants signed the informed con-
sent form, and the study was approved by the Bolivian
Ministry of Health.
HIV-1 DNA amplification and sequencing
Genomic DNA was extracted from whole blood by the
phenol/chloroform method from samples collected in
1996, as described [25]. For samples collected in 2005,
the QIAamp DNA kit was used (Qiagen Inc., CA, U.S.
A.) according to the manufacturer’s protocol.
Figure 3 Schematic representation of the BF1 mosaic structure from clusters 10, 11 and CRF12. Both genomic structures were drawn by
using the Recombinant Draw Toll available in the Los Alamos homepage (http://www.hiv.lanl.gov/content/hiv-db/DRAW_CRF/recom_mapper.
html).
Table 1 HIV-1 genetic forms identified in the 51 HIV-1
samples from Bolivia in two distinct time periods (1996
and 2005)
Genotype 1996 (n = 21) % 2005 (n = 30) %
B pol/B env 16 76.2 21 70
BF1 recombinants 5 23.8 9 30
F1 pol/B env 2 9.5 0 0
CRF12-like pol/B env 1 4.8 0 0
CRF12-like pol/F1 env 1 4.8 3 10
CRF12-related pol/F1 env 0 0 6 20
CRF17-like pol/F1 env 1 4.8 0 0
List of abbreviations: HIV-1 Human immunodeficiency virus-1, pol Polymerase,
pr/rt Protease/reverse transcriptase, env Envelope, NJ neighbor-joining, CRF
Circulating recombinant forms, URF Unique recombinant forms, AIDS Acquired
immune deficiency syndrome, HMA Hetereduplex mobility assay, DNA
Deoxyribonucleic acid
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Amplification of HIV-1 env and pol regions was per-
formed using an in-house nested PCR protocol method
as described elsewhere [29]. Samples collected in 1996
were previously subtyped based on the HMA env-gp120
C2-V3 region and 11 of them were also sequenced and
phylogenetically analyzed as described [25]. Partial pro-
tease/reverse transcriptase (pr/rt) sequences were gener-
ated for the samples from both periods, and new env
sequences were obtained only from samples collected in
2005. No HIV-1 seropositive individuals from the first
time period were undergoing antiretroviral therapy at
the time of blood collection; however, more than a half
of the individuals in the second group were being
treated.
HIV-1 subtype classification
HIV-1 subtype classification was performed by phyloge-
netic analysis with the neighbor-joining method using
the Tamura-Nei model as implemented in Mega 4.0
[30]. Those samples that present divergent clustering in
the phylogenetic analysis were investigated for recombi-
nation by bootscan analysis as implemented in the Sim-
plot version 3.5.1 (http://www.med.jhu.edu/deptmed/
sray/download/), using representative HIV-1 sequences
from group M. Bootstrap values supporting branching
with reference sequences were determined in neighbor-
joining trees constructed using the Kimura 2-parameter
model, based on 100 re-samplings, with a 200 nucleotide
sliding window moving in steps of 20 bases. The Split-
sTree program version 4 [31] was employed to confirm
the phylogenetic relationship of the recombinant sam-
ples using the NeighborNet based on the pairwise dis-
tance estimated by F84 parameter model.
Sequence data
GenBank accession numbers: JN710748-JN710798 (env-
gp120 C2-V3 region), JN710799-JN710830 (pr/rt).
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